Jordan Lormor, LPTA | |
185 Cornerstone Ln, Hot Springs, AR 71913-6500 | |
(501) 525-4855 | |
Not Available |
Full Name | Jordan Lormor |
---|---|
Gender | Female |
Speciality | Physical Therapy Assistant |
Location | 185 Cornerstone Ln, Hot Springs, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528660800 | NPI | - | NPPES |
2156700 | Other | TX | LICENSED PHYSICAL THERAPIST ASSISTANT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2081P0010X | Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine | 2156700 (Texas) | Secondary |
225200000X | Physical Therapy Assistant | 2156700 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jordan Lormor, LPTA 1620 Ringtail Dr, Wylie, TX 75098-6696 Ph: (469) 879-2195 | Jordan Lormor, LPTA 185 Cornerstone Ln, Hot Springs, AR 71913-6500 Ph: (501) 525-4855 |
News Archive
As the debate surrounding the Affordable Care Act (ACA) looms in the U.S. Congress, Johns Hopkins researchers are weighing in on one aspect of the law. In 2014, as part of the ACA, Maryland was one of the states that expanded eligibility for its Medicaid program.
A new study links anxiety, a brain structure called the orbitofrontal cortex, and optimism, finding that healthy adults who have larger OFCs tend to be more optimistic and less anxious.
Scientists at the University of Liverpool and Callaghan Innovation in New Zealand have developed a new chemical approach to help harness the natural ability of complex sugars to treat Alzheimer's disease.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Application (sNDA) seeking approval of DACOGEN (decitabine) for injection in the treatment of acute myeloid leukemia.
Malignant melanoma can be a particularly dangerous form of cancer, and more therapeutic options are needed. Now, researchers report in ACS Medicinal Chemistry Letters that a bacteria from seawater has inspired promising leads for an entirely new way to treat the disease.
› Verified 2 days ago